zephyr

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

Source Node:
Time Stamp: February 2, 2024 2:30 PM - Modified On: February 2, 2024 - Published By:
Source Cluster:
Republished By Plato

  New York, Feb 2, 2024 - (Plato Data)- Fortress Biotech (Fortress Bio), a unique biotech company led by industry veteran Dr. Lindsay Rosenwald, focused on identifying, in-licensing and developing high-potential marketed drugs and development-stage drug candidates in-house and through its subsidiary partner companies, has announced multiple new milestones to start 2024 with a bang. Avenue Therapeutics Finalizes Phase 3 Study for IV Tramadol with FDA Avenue Therapeutics, a subsidiary of Fortress Bio, has reached a significant milestone in its quest to introduce new therapies for neurologic diseases. The company

Plato Data Intelligence Leverages Vectara to Power its Data-As-A-Service / DaaS Platform

Source Node:
Time Stamp: January 18, 2024 1:36 PM - Modified On: January 18, 2024 - Published By:
Source Cluster:
Republished By Plato

From development to launch, Vectara’s GenAI technology and team help innovators get to market faster. The announced partnership breaks new ground towards deploying a next generation of GenAI tools with Vertical focus. Vectara, the Trusted Generative AI Product Platform, and Plato Data Intelligence, creators of PlatoAi, have entered into a commercial agreement to unlock the power of Vectara via Plato AI’s Generative Intelligence platform. With an emphasis on secure, trustworthy, and transparent GenAI for enterprises, Vectara was the clear choice for developers who want a trusted provider to count on

Clinical Squared and PlatoHealth Join Forces to Revolutionize Healthcare with Advanced Data Orchestration Powered by AI.

Source Node:
Time Stamp: September 20, 2023 12:29 PM - Modified On: September 20, 2023 - Published By:
Source Cluster:
Republished By Plato

Washington DC, September 20th, 2023 — Clinical Squared (C2) and Platohealth.ai are delighted to announce a groundbreaking partnership that promises to reshape the healthcare landscape. Their collaboration brings together the healthcare expertise of C2 and the cutting-edge AI and machine learning capabilities of Plato.ai to create innovative solutions. [gallery columns="2" link="none" size="large" ids="2890769,2890768"] Clinical Squared, a leader in healthcare market expertise, data architecture, software development, consultation and implementation services, will lend its extensive industry knowledge to Plato.ai's platform. In turn, Plato.ai will provide advanced AI and machine learning mechanisms to

Government Blockchain Association (GBA) Deploys PlatoAi across GBA’s Opensource Intelligence Platform (OSINT)

Source Node:
Time Stamp: July 6, 2023 11:45 AM - Modified On: July 6, 2023 - Published By:
Source Cluster:
Republished By Plato

Washington DC, July 6th, 2023. Government Blockchain Association (GBA) announced the successful deployment of PlatoAi’s Ai Powered Web3 Intelligence inside the GBA Members Site. The result of this successful deployment stemmed from a strategic partnership between the two companies with a collective vision and deep commitment towards driving commercial adoption, standards and regulatory compliance of global government blockchain initiatives. Through this deployment GBA’s community will immediately benefit by accessing the latest premium intelligence across 36 Market Verticals including Ai, Digital Assets, Regulatory Initiatives, Web3, NFT’s, CyberSecurity, ESG and Carbon Offsets.

Redmatter.Capital Deploys PlatoAi across its Web3 Content and Data Intelligence

Source Node:
Time Stamp: June 12, 2023 11:57 AM - Modified On: June 12, 2023 - Published By:
Source Cluster:
Republished By Plato

Montenegro, June 10th, 2023. Redmatter.Capital a fully regulated platform digital assets today announced the successful deployment of PlatoAi’s Ai Powered Web3 Intelligence inside the Redmatter Platform. The result of this successful deployment stemmed from a strategic partnership between the two companies with a collective vision and deep commitment towards driving commercial adoption and regulatory compliance of Digital Assets. Through this deployment Redmatter’s community of users will immediately benefit by accessing the latest premium intelligence across the digital asset sector including Web3, NFT’s, Trading and Carbon Offsets. Both companies plan to